Experts discuss best practices for educating patients with multiple myeloma on the adverse effects associated with talquetamab treatment.
Stay up to date on recent advances in oncology nursing and patient care.
What Should Oncology Nurses Know About Biology-Guided RT?
Finley-Oliver Talks Talquetamab and Other Later Line Multiple Myeloma Therapies
Q&A: Nursing Considerations From Immune Cell Effector Therapy Experts
Beth Faiman Discusses Recent Changes in Multiple Myeloma Treatment Landscape
Linvoseltamab Gains FDA Accelerated Approval In R/R Myeloma
FDA Relaxes REMS, Monitoring Rules for Liso-Cel and Ide-Cel
Nurses, APPs Key to AE Management as T-Cell Engagers Move Into Solid Tumors
PI3K and AKT Inhibitor Toxicity Advice From a Breast Cancer Expert
Sonrotoclax/Zanubrutinib Generates Durable Response in R/R MCL